GSK (GSK) and LTZ Therapeutics announced a strategic research collaboration to advance the development of novel myeloid cell engagers, MCEs, to ...

GSK teams with LTZ Therapeutics to co-develop next-gen myeloid-cell engager immunotherapies in oncology leveraging LTZ’s ...

Under the terms of the agreements, if GSK elects to progress into a further collaboration, ProFound and Quotient will advance their respective programs through key preclinical activities, after which ...

Darby Dental Supply has agreed to distribute GlaxoSmithKline (GSK) oral care products. Under the terms of the new distribution agreement, Darby is now an authorized distributor of GSK's full line of ...

Sino-American immunotherapy-focused biotech LTZ Therapeutics and UK pharma major GSK have entered into a strategic research ...

GSK GSK boasts a diversified base and presence in different geographical areas. The company has made significant progress in expanding its presence in emerging markets by acquiring product portfolios ...

It’s been an upbeat week for GSK as it reported a trio of positive updates stemming from vaccines and oncology products. Most notable, perhaps, was the news that the British drugmaker took a step ...

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this ...

GSK trades at lower price multiples compared to competitors due to weaker pipeline. GSK's revenue growth in 2023 was modest, but it has strong performers in its product mix. GSK needs to demonstrate ...

LONDON/MUMBAI (Reuters) - Indian generics firm Lupin , some U.S. drugmakers looking for a tax-saving deal in Europe and private equity funds are planning to bid for a range of older drugs being ...

BEIJING/LONDON, Oct 31 (Reuters) - China has blocked GSK (GSK.L), opens new tab from participating in its bulk-buy drug procurement programme focused on off-patent medicines from Oct. 31 until April ...